These proteins inhibit cell cycle progression; therefore, CDKN2A/B HD may disrupt the regulatory mechanisms controlling tumor cell proliferation, potentially leading to increased protein synthesis and MET accumulation [21]. This evidence concerns the gene CDKN2A and neoplasm.